Phantom PAINS: Problems with the Utility of Alerts for Pan-Assay INterference CompoundS

The use of substructural alerts to identify Pan-Assay INterference compoundS (PAINS) has become a common component of the triage process in biological screening campaigns. These alerts, however, were originally derived from a proprietary library tested in just six assays measuring protein-protein interaction (PPI) inhibition using the AlphaScreen detection technology only; moreover, 68% (328 out of the 480 alerts) were derived from four or fewer compounds. In an effort to assess the reliability of these alerts as indicators of pan-assay interference, we performed a large-scale analysis of the impact of PAINS alerts on compound promiscuity in bioassays using publicly available data in PubChem. We found that the majority (97%) of all compounds containing PAINS alerts were actually infrequent hitters in AlphaScreen assays measuring PPI inhibition. We also found that the presence of PAINS alerts, contrary to expectations, did not reflect any heightened assay activity trends across all assays in PubChem including AlphaScreen, luciferase, beta-lactamase, or fluorescence-based assays. In addition, 109 PAINS alerts were present in 3570 extensively assayed, but consistently inactive compounds called Dark Chemical Matter. Finally, we observed that 87 small molecule FDA-approved drugs contained PAINS alerts and profiled their bioassay activity. Based on this detailed analysis of PAINS alerts in nonproprietary compound libraries, we caution against the blind use of PAINS filters to detect and triage compounds with possible PAINS liabilities and recommend that such conclusions should be drawn only by conducting orthogonal experiments.

[1]  Igor V. Tetko,et al.  Identification of Small-Molecule Frequent Hitters from AlphaScreen High-Throughput Screens , 2014, Journal of biomolecular screening.

[2]  L. Gottschalk,et al.  Guidelines for Authors , 2015, Avian diseases.

[3]  Daniel A Erlanson,et al.  Learning from PAINful lessons. , 2015, Journal of medicinal chemistry.

[4]  Maria F. Sassano,et al.  Colloidal Aggregation Causes Inhibition of G Protein-Coupled Receptors , 2013, Journal of medicinal chemistry.

[5]  Michelle R. Arkin,et al.  Tackling reproducibility in academic preclinical drug discovery , 2015, Nature Reviews Drug Discovery.

[6]  Alexander Tropsha,et al.  Predicting chemically-induced skin reactions. Part I: QSAR models of skin sensitization and their application to identify potentially hazardous compounds. , 2015, Toxicology and applied pharmacology.

[7]  John J. Irwin,et al.  ZINC 15 – Ligand Discovery for Everyone , 2015, J. Chem. Inf. Model..

[8]  A. Tropsha.  Alarms about Structural Alerts , 2016 .

[9]  Anne Mai Wassermann,et al.  Dark chemical matter as a promising starting point for drug lead discovery. , 2015, Nature chemical biology.

[10]  Tudor I. Oprea,et al.  Drug Repurposing: Far Beyond New Targets for Old Drugs , 2012, The AAPS Journal.

[11]  Julie Clark,et al.  Open Source Drug Discovery: Highly Potent Antimalarial Compounds Derived from the Tres Cantos Arylpyrroles , 2016, ACS central science.

[12]  Jayme L. Dahlin,et al.  How to Triage PAINS-Full Research. , 2016, Assay and drug development technologies.

[13]  M. R. Senger,et al.  Filtering promiscuous compounds in early drug discovery: is it a good idea? , 2016, Drug discovery today.

[14]  Jonathan B Baell,et al.  Feeling Nature's PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS). , 2016, Journal of natural products.

[15]  Jonathan B Baell,et al.  Screening-based translation of public research encounters painful problems. , 2015, ACS medicinal chemistry letters.

[16]  F. Collins,et al.  Policy: NIH plans to enhance reproducibility , 2014, Nature.

[17]  Olivier Sperandio,et al.  FAF-Drugs3: a web server for compound property calculation and chemical library design , 2015, Nucleic Acids Res..

[18]  Alexander Tropsha,et al.  QSAR models of human data can enrich or replace LLNA testing for human skin sensitization. , 2016, Green chemistry : an international journal and green chemistry resource : GC.

[19]  Jayme L. Dahlin,et al.  PAINS in the Assay: Chemical Mechanisms of Assay Interference and Promiscuous Enzymatic Inhibition Observed during a Sulfhydryl-Scavenging HTS , 2015, Journal of medicinal chemistry.

[20]  James Inglese,et al.  Apparent activity in high-throughput screening: origins of compound-dependent assay interference. , 2010, Current opinion in chemical biology.

[21]  Péter Mátyus,et al.  One size does not fit all: Challenging some dogmas and taboos in drug discovery. , 2016, Future medicinal chemistry.

[22]  Vinicius M. Alves,et al.  Alarms about structural alerts. , 2016, Green chemistry : an international journal and green chemistry resource : GC.

[23]  Ian A. Watson,et al.  Rules for identifying potentially reactive or promiscuous compounds. , 2012, Journal of medicinal chemistry.

[24]  Jayme L. Dahlin,et al.  Assay Interference by Chemical Reactivity , 2015 .

[25]  Tudor I. Oprea,et al.  Badapple: promiscuity patterns from noisy evidence , 2016, Journal of Cheminformatics.

[26]  Jürgen Bajorath,et al.  Determining the Degree of Promiscuity of Extensively Assayed Compounds , 2016, PloS one.

[27]  Ruth Brenk,et al.  Locating Sweet Spots for Screening Hits and Evaluating Pan-Assay Interference Filters from the Performance Analysis of Two Lead-like Libraries , 2013, J. Chem. Inf. Model..

[28]  J Willem M Nissink,et al.  Quantification of frequent-hitter behavior based on historical high-throughput screening data. , 2014, Future medicinal chemistry.

[29]  Stephan C Schürer,et al.  BioAssay Ontology Annotations Facilitate Cross-Analysis of Diverse High-Throughput Screening Data Sets , 2011, Journal of biomolecular screening.

[30]  Anne E Carpenter,et al.  Discovery of New Anti-Schistosomal Hits by Integration of QSAR-Based Virtual Screening and High Content Screening. , 2016, Journal of medicinal chemistry.

[31]  Alexander Tropsha,et al.  Predicting chemically-induced skin reactions. Part II: QSAR models of skin permeability and the relationships between skin permeability and skin sensitization , 2015, Toxicology and applied pharmacology.

[32]  Alexander Tropsha,et al.  Expanding the scope of drug repurposing in pediatrics: the Children's Pharmacy Collaborative. , 2014, Drug discovery today.

[33]  Patrick R. Griffin,et al.  PubChem promiscuity: a web resource for gathering compound promiscuity data from PubChem , 2012, Bioinform..

[34]  J. Baell,et al.  New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. , 2010, Journal of medicinal chemistry.